Increased ABL1 kinase activity occurs in a subset of T-ALL patients due to the NUP214-ABL1 gene fusion [55], and another ABL1 fusion, BCR-ABL1, has been shown to activate NF-κB in myeloid leukemic cells [101,102]. The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.